… many patients who are receiving long-acting bronchodilators … LABA/LAMA FDCs in the
treatment of stable COPD were more … the New Zealand PREDICT Cardiovascular Disease Cohort …

… combinations in patients with stable COPD is supported by … number of independent factors
predictive of clinical outcomes [… of the long-acting bronchodilators aclidinium and formoterol …

… eosinophils in patients with exacerbations predict response to … patients with COPD on a
single long-acting bronchodilator … use of a LAMA and LABA dual bronchodilator (available as a …

… of the treatment for COPD patients was … bronchodilators and long-acting bronchodilators
including LAMA, LABA, SAMA, SABA and ICS are frequently applied in the treatment of COPD […

… Patients with stable COPD were randomized 2:1 to receive BAT/FF 300/100 or placebo …
effect of various bronchodilators and have proven to be reliable in predicting the possible …

… Long-acting bronchodilators are the cornerstone in the … for ICS use in stable COPD patients
having exacerbations [38]. In … the role of eosinophil levels in predicting the response to ICS. …

… Long-acting bronchodilator therapy is the cornerstone treatment for patients with COPD; …
Poor lung function and comorbidities were predictive of poor inhaler technique in some patients, …

… as a predictive biomarker to identify COPD patients in whom … Patients with severe COPD
and a history of multiple exacerbations despite appropriate long-acting bronchodilator treatment …

… -acting bronchodilator responsiveness … be predictive of clinical response to long-acting
bronchodilators (22) and may not be predictive of clinical response to long-acting bronchodilators …

… The best predictor of future COPD exacerbation is a history of COPD exacerbation. … Initial
treatment per guidelines is to start a single-agent, long-acting bronchodilator, with a preference …